Design and structure of symmetry-based inhibitors of HIV-1 protease

Summary

The concept of active-site symmetry along with structural and mechanistic considerations of aspartic proteases has been used to design novel,C 2-symmetry-based inhibitors of HIV PR. A comparative molecular-modeling strategy was used in the design of a pseudo-C 2-symmetric diaminoalcohol series and later a diastereomeric series ofC 2-symmetric diaminodiols. The structure of the pseudosymmetric alcohol A-74704, complexed with HIV PR, confirmed the proposed symmetric mode of binding, and also proved useful in subsequent efforts to improve the solubility of the more potent diol series. The crystal-structure analysis of a pseudosymmetricR,S-diol provided insights into the relative contributions of the two hydroxyl groups to the stability of the complex. A comparison of the binding modes for symmetric and asymmetric, substrate-based inhibitors indicates that the influence of symmetry on binding is mainly expressed at the protein level, since the overall subsite symmetry is maintained even with highly asymmetric inhibitors. Thus, while the incorporation ofC 2 symmetry does not necessarily lead to compounds with improved potency over asymmetric compounds, this strategy has led to the design of structurally novel and perhaps pharmacologically desirable inhibitors. The growing number of examples of symmetry-based inhibitors is evidence that symmetry has become a useful paradigm for HIV protease inhibitor design and that structure-based approaches to inhibitor design can contribute in unique and critical ways to the conceptualization of medicinal chemistry strategies that can lead to useful clinical candidates for AIDS, cancer and other diseases.

This is a preview of subscription content, access via your institution.

References

  1. 1

    Mitsuya, H., Yarchoan, R. and Broder, S., Science, 249 (1990) 1533.

    Google Scholar 

  2. 2

    Erickson, J.W. and Fesik, S.W., Annu. Rep. Med. Chem., 727 (1992) 271.

    Google Scholar 

  3. 3

    Erickson, J. and Kempf, D., In Proceedings of the Third International Positive Strand RNA Virus Conference, 1993, in press.

  4. 4

    Kempf, D.J., Norbeck, D.W., Codacovi, L., Wang, X.C., Kohlbrenner, W.F., Wideburg, N.E., Saldivar, A., Craig-Kennard, A., Vasavanonda, S., Clement, J.J. and Erickson, J., In Bentley, P.H. and Ponsford, R. (Eds.) Recent Advances in the Chemistry of Anti-infective Agents, Royal Society of Chemistry, Cambridge University Press, Cambridge, 1993, pp. 247–313.

    Google Scholar 

  5. 5

    Kempf, D.J., Meth. Enzymol., (1993), in press.

  6. 6

    Wlodawer, A. and Erickson, J.W., Annu. Rev. Biochem., 62 (1993) 543.

    Google Scholar 

  7. 7

    Appelt, K., Perspect. Drug Dis. Design, 1 (1993) in press.

  8. 8

    Debouck, C., AIDS Res. Hum. Retrov., 8 (1992) 153.

    Google Scholar 

  9. 9

    Kohl, N.E., Emini, E.A., Schleif, W.A., Davis, L.J., Heimbach, J.C., Dixon, R.A.F., Scolnick, E.M. and Sigal, I.S., Proc. Natl. Acad. Sci. USA, 85 (1988) 4686.

    Google Scholar 

  10. 10

    Toh, H., Ono, M., Saigo, K. and Miyata, T., Nature, 315 (1985) 691.

    Google Scholar 

  11. 11

    Katoh, I., Yasunaga, T., Ikawa, Y. and Yoshinaka, Y., Nature, 329 (1987) 654.

    Google Scholar 

  12. 12

    Davies, D.R., Annu. Rev. Biophys. Biophys. Chem., 19 (1990) 189.

    Google Scholar 

  13. 13

    Tang, J., James, M.N.G., Hsu, I.N., Jenkins, J.A. and Blundell, T.L., Nature, 271 (1978) 618.

    Google Scholar 

  14. 14

    Miller, M., Jaskolski, M., Rao, J.K.M., Leis, J. and Wlodawer, A., Nature, 337 (1989) 576.

    Google Scholar 

  15. 15

    Navia, M.A., Fitzgerald, P.M.D., McKeever, B.M., Leu, C.T., Heimbach, J.C., Herber, W.K., Sigal, I.S., Darke, P.L. and Springer, J.P., Nature, 337 (1989) 615.

    Google Scholar 

  16. 16

    Wlodawer, A., Miller, M., Jaskolski, M., Sathyanarayana, B.K., Baldwin, E., Weber, I.T., Self, L.M., Clawson, L., Schneider, J. and Kent, S.B.M., Science, 245 (1989) 616.

    Google Scholar 

  17. 17

    Lapatto, R., Blundell, T., Hennings, A., Overington, J., Wilderspin, A., Wood, S., Merson, J.R., Whittle, P.J., Danley, D.E., Geoghegan, K.F., Hawrylik, S.J., Lee, S.E., Scheld, K.G. and Hobart, P.M., Nature, 342 (1989) 299.

    Google Scholar 

  18. 18

    Spinelli, S., Liq, Q.Z., Alzari, P.M., Hirel, P.H. and Poljak, R.J., Biochimie, 73 (1991) 1391.

    Google Scholar 

  19. 19

    York, D.M., Darden, T.A., Pedersen, L.G. and Anderson, M.W., Biochemistry, 32 (1993) 1443.

    Google Scholar 

  20. 20

    Rao, J.K.M., Erickson, J.W. and Wlodawer, A., Biochemistry, 30 (1991) 4663.

    Google Scholar 

  21. 21

    Greenlee, W.J., Med. Res. Rev., 10 (1990) 173.

    Google Scholar 

  22. 22

    Meek, T.D., J. Enzyme Inhib., 6 (1992) 65.

    Google Scholar 

  23. 23

    Huff, J.R., J. Med. Chem., 34 (1991) 2305.

    Google Scholar 

  24. 24

    Norbeck, D.W. and Kempf, D.J., Annu. Rep. Med. Chem., (1991) 141.

  25. 25

    Tomasselli, A.G., Howe, W.J., Sawyer, T.K., Wlodawer, A. and Heinrikson, R.L., Chimica Oggi, 9 (1991) 6.

    Google Scholar 

  26. 26

    Erickson, J., Neidhart, D.J., VanDrie, J., Kempf, D.J., Wang, X.C., Norbeck, D.W., Plattner, J.J., Rittenhouse, J.W., Turon, M., Wideburg, N., Kohlbrenner, W.E., Simmer, R., Helfrich, R., Paul, D.A. and Knigge, M., Science, 249 (1990) 527.

    Google Scholar 

  27. 27

    Kempf, D.J., Codacovi, L., Wang, X.C., Norbeck, D.W., Kohlbrenner, W.E., Wideburg, N.E., Paul, D.A., Knigge, M.F., Vasavanonda, S., Craig-Kennard, A., Saldivar, A., Rosenbrook Jr., W., Clement, J.J., Plattner, J.J. and Erickson, J., J. Med. Chem., 33 (1990) 2687.

    Google Scholar 

  28. 28

    Pearl, L.H. and Taylor, W.R., Nature, 329 (1987) 351.

    Google Scholar 

  29. 29

    Suguna, K., Padlan, E.A., Smith, C.W., Carlson, W.D. and Davies, D.R., Proc. Natl. Acad. Sci. USA, 84 (1987) 7009.

    Google Scholar 

  30. 30

    Matayoshi, E.D., Wang, G.T., Krafft, G.A. and Erickson, J., Science, 247 (1990) 954.

    Google Scholar 

  31. 31

    Miller, M., Schneider, J., Sathyanarayana, B.K., Toth, M.V., Marshall, G.R., Clawson, L., Selk, L., Kent, S.B.H. and Wlodawer, A., Science, 246 (1989) 1149.

    Google Scholar 

  32. 32

    Luly, J.R., BaMaung, N., Soderquist, J., Fung, A.K.L., Stein, H., Kleinert, H.D., Marcotte, P.A., Egan, D., Bopp, B., Merits, I., Bolis, G., Greer, J., Perun, T. and Plattner, J.J., J. Med. Chem., 31 (1988) 2264.

    Google Scholar 

  33. 33

    Chenera, B., Boehm, J.C. and Dreyer, G.B., Bioorg. Med. Chem. Lett., 4 (1991) 219.

    Google Scholar 

  34. 34

    Kempf, D.J., Codacovi, L., Wang, X.C., Kohlbrenner, W.E., Wideburg, N.E., Saldivar, A., Vasavanonda, S., Marsh, K.C., Bryant, P., Sham, H.L., Green, B.E., Betebenner, D.A., Erickson, J. and Norbeck, D.W., J. Med. Chem., 36 (1992) 320.

    Google Scholar 

  35. 35

    Kempf, D.J., March, K., Paul, M.F., Knigge, D.W., Norbeck, W.E., Kohlbrenner, W.E., Codacovi, L., Vasavanonda, S., Bryant, P., Wang, X.C., Wideburg, N.E., Clement, J.J., Plattner, J.J. and Erickson, J., Antimicrob. Agent Chemother., 35 (1991) 2209.

    Google Scholar 

  36. 36

    Dreyer, B.G., Boehm, J.C., Chenera, B., DesJarlais, R.L., Hassell, A.M., Meek, T.D. and Tomaszek Jr., T.A., Biochemistry, 32 (1993) 937.

    Google Scholar 

  37. 37

    Peyman, A., Budt, K.H., Spanig, J., Stowasser, B. and Ruppert, D., Tetrahedron Lett., 33 (1992) 4549.

    Google Scholar 

  38. 38

    Sham, H.L., Wideburg, N.E., Spanton, S.G., Kohlbrenner, W.E., Betebenner, D.A., Kempf, D.J., Norbeck, D.W., Plattner, J.J. and Erickson, J., J. Chem. Soc., Chem. Commun. (1991) 110.

  39. 38

    Babine, R.E., Zhang, N., Jurgens, A.R., Schow, S.R., Desai, P.R., James, J.C. and Semmelhack, M.F., Bioorg. Med. Chem. Lett., 2 (1992) 541.

    Google Scholar 

  40. 40

    Bone, R., Vacca, J.P., Anderson, P.S. and Holloway, M.K., J. Am. Chem. Soc., 113 (1991) 9382.

    Google Scholar 

  41. 41

    Lyle, T.A., Wiscount, C.M., Guare, J.P., Thompson, W.J., Anderson, P.S., Darke, P.S., Zugay, J.A., Emini, W.A., Schleif, W.A., Quintero, J.C., Dixon, R.A.F., Sigal, I.S. and Huff, J.R., J. Med. Chem., 34 (1991) 1228.

    Google Scholar 

  42. 42

    Humber, D.C., Cammack, N., Coates, J.A.V., Cobley, K.N., Orr, D.C., Storer, R.D., Weingarten, G.G. and Weir, M.P., J. Med. Chem., 35 (1992) 3080.

    Google Scholar 

  43. 43

    Humber, D.C., Cobley, K.N., Evans, D.N., Storer, R., Weingarten, G.G., Hann, M.M., Mistry, A., Wonacott, A., Cammack, N. and Orr, D.C., VIIIth International Conference on AIDS, Amsterdam, 19–24 July 1992, POA 2280.

  44. 44

    Kageyama, S., Mimoto, T., Murakawa, Y., Nomizu, M., Fort Jr., H., Shirasaka, T., Gulnik, S., Erickson, J., Takada, K., Hayashi, H., Broder, S., Kiso, Y. and Mitsuya, H., Antimicrob. Agents Chemother., 37 (1993) in press.

  45. 45

    Dreyer, B.G., Lambert, D.M., Meek, T.D., Carr, T.J., Tomaszek Jr., T.A., Fernandez, A.V., Bartus, H., Cacciavillani, E., Hassell, A.M., Minnich, M., Petteway Jr., S.R. and Metcalf, B.W., Biochemistry, 31 (1992) 6646.

    Google Scholar 

  46. 46

    Murthy, K.H.M., Winborne, E.L., Minnich, M.D., Culp, J.S. and Debouck, C., J. Biol. Chem., 267 (1992) 22770.

    Google Scholar 

  47. 47

    Fitzgerald, P.M.D., McKeever, B.M., VanMiddleworth, J.F., Springer, J.P., Heimbach, J.C., Leu, C.-T., Herber, W.K., Dixon, R.A.F. and Darke, P.L., J. Biol. Chem., 265 (1990) 14209.

    Google Scholar 

  48. 48

    Lam, P.Y.-S., Eyermann, J., Hodge, C.N., Jadhav, P.K., Ru, Y., Bacheler, L.T., Meek, J.L., Otto, M.J., Rayner, M.M., Wong, N.Y., Chang, C.H., Weber, P.C., Jackson, D.A., Sharpe, T.R. and Erickson-Viitanen, S.K., 205th American Chemical Society National Meeting, Denver, CO, 1993, 96.

  49. 49

    Swain, A.L., Miller, M.M., Green, J., Rich, D.H., Schneider, J., Kent, S.B. and Wlodawer, A., Proc. Natl. Acad. Sci. USA, 87 (1990) 8805.

    Google Scholar 

  50. 50

    Friedman, S.H., DeCamp, D.L., Sijbesma, R.P., Srdanov, G., Wudl, F. and Kenyon, G.L., J. Am. Chem. Soc., 115 (1993) 6506.

    Google Scholar 

Download references

Author information

Affiliations

Authors

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Erickson, J.W. Design and structure of symmetry-based inhibitors of HIV-1 protease. Perspectives in Drug Discovery and Design 1, 109–128 (1993). https://doi.org/10.1007/BF02171658

Download citation

Key words

  • AIDS
  • HIV protease
  • Drug design
  • Symmetric inhibitors
  • X-ray crystallography